Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01799252 · ClinicalTrials.gov registry record
Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion
A clinical trial, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- 582
- Enrollment target
NCT01799252: Completed study, sponsored by Gynuity Health Projects.
NCT01799252 is a clinical trial that has completed, run by Gynuity Health Projects. The registered enrollment target is 582 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01799252 has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- 582 participants
- Enrollment target
Study Summary
The effectiveness of antibiotic treatment at reducing post-abortion infection is unclear. The experiences of women prescribed routine antibiotics after medical abortion is missing from the existing evidence. This study seeks to add to the literature evidence of the side effects associated with antibiotic treatment that women experience and their adherence to prescribed regimens.
Primary Outcome
Compare the incidence rates of nausea between women who are prescribed a seven-day regimen of doxycycline to women who are not prescribed antibiotics following medical abortion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 582 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-12 |
What the finished NCT01799252 record still lists
NCT01799252 is an observational study that tracks outcomes without assigning an intervention. The registered 582 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01799252 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01799252 about?
NCT01799252 is a clinical study titled "Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion". The effectiveness of antibiotic treatment at reducing post-abortion infection is unclear. The experiences of women prescribed routine antibiotics after medical abortion is missing from the existing evidence. This study seeks to add to the literature evidence of the side effects associated with antib...
What is the current status of trial NCT01799252?
This trial is currently completed. The enrollment target is 582 participants. The study started on 2012-11. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT01799252?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06350097 · 582 participants · Phase 3
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- NCT06563895 · 582 participants · Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- NCT06819007 · 582 participants · Phase 3
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia